| 2nd Oct 2026 7:00 am |
RNS-R |
Australian partner to progress Ox-1 Phase 1 trial |
| 30th Sep 2026 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 28th Sep 2026 7:00 am |
RNS |
Final Results for the year ended 31 March 2026 |
| 14th Sep 2026 7:00 am |
RNS |
Notice of Results and Investor Presentation |
| 11th Sep 2026 3:52 pm |
RNS |
Holding(s) in Company |
| 10th Sep 2026 12:33 pm |
RNS |
Holding(s) in Company |
| 7th Sep 2026 12:15 pm |
RNS |
Result of General Meeting |
| 20th Aug 2026 4:13 pm |
RNS |
Proposed Placing & Subscription to raise £1.05m |
| 24th Jun 2026 4:34 pm |
RNS |
Holding(s) in Company |
| 26th May 2026 2:40 pm |
RNS |
Holding(s) in Company |
| 15th May 2026 12:43 pm |
RNS |
Holding(s) in Company |
| 15th May 2026 7:00 am |
RNS |
Holding(s) in Company |
| 14th May 2026 7:00 am |
RNS |
Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am |
RNS-R |
Investor Webinar |
| 20th Apr 2026 7:00 am |
RNS |
Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am |
RNS |
New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am |
RNS |
Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am |
RNS |
Ox-1 Programme Advances to Final Toxicology Study |
| 26th Jan 2026 7:00 am |
RNS |
Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am |
RNS |
Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am |
RNS-R |
Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am |
RNS |
Half-year Financial Report |
| 26th Nov 2025 7:00 am |
RNS-R |
Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am |
RNS |
Notice of Results |
| 3rd Nov 2025 7:00 am |
RNS |
Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm |
RNS |
Holding(s) in Company |
| 16th Oct 2025 4:45 pm |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am |
RNS-R |
World Mental Health Day & Q4 Conference Schedule |
| 26th Sep 2025 3:45 pm |
RNS |
Holding(s) in Company |
| 8th Sep 2025 11:38 am |
RNS |
Holding(s) in Company |
| 4th Sep 2025 7:00 am |
RNS |
Ox-1 Patent Grant & Development Programme Update |
| 4th Aug 2025 3:27 pm |
RNS |
Holding(s) in Company |
| 17th Jul 2025 7:00 am |
RNS |
Manufacturing Scale Up of Lead Ox-1 Programme |
| 9th Jul 2025 3:07 pm |
RNS |
Result of AGM |
| 9th Jul 2025 7:00 am |
RNS |
AGM Statement |
| 16th Jun 2025 4:10 pm |
RNS |
Notice of AGM |
| 13th Jun 2025 7:00 am |
RNS |
Change of Adviser |
| 10th Jun 2025 12:32 pm |
RNS-R |
Ox-1 Investor Presentation |
| 3rd Jun 2025 7:00 am |
RNS |
Final results for year to 31 March 2025 |
| 23rd May 2025 7:14 am |
RNS |
Notice of Results and Ox-1 presentation |
